Precision High-Intensity Training Through Epigenetics (PHITE)
PHITE
1 other identifier
interventional
239
1 country
1
Brief Summary
The PHITE collaborative team, consisting of Tim Broderick, MD (Overall PI), Wright State University (WSU); Marcas Bamman, PhD (Site PI), The University of Alabama at Birmingham (UAB); and Ron Evans, PhD and Joe Ecker, PhD, Salk Institute for Biological Studies, are working with funding from the US Department of Defense (DoD), Office of Naval Research (ONR), to explore the link between physical training and epigenetics. This is a key interest area for the DoD ONR because it provides high-impact optimization of force readiness in warfighters with diverse backgrounds. The term epigenetics refers to heritable changes in gene expression (active versus inactive genes) that does not involve changes to the underlying DNA sequence; a change in phenotype (the set of observable characteristics of an individual resulting from the interaction of its genotype with the environment) without a change in genotype (the genetic constitution of an individual organism) . This in turn affects how cells read the genes. Epigenetic change is a regular and natural occurrence but can also be influenced by several factors including age, the environment/lifestyle, and disease state. Epigenetic modifications can manifest as commonly as the manner in which cells terminally differentiate to end up as skin cells, liver cells, brain cells, etc. New and ongoing research is continuously uncovering the role of epigenetics in a variety of human conditions. This study is designed to assess whether epigenetics is a primary mechanism modulating how individuals adapt to specific exercise training prescriptions designed to produce a warfighter phenotype. The PHITE team is organized around a shared test population of human subjects for which UAB will oversee recruitment, training, testing, and sampling. Healthy but untrained volunteers, both men and women, 18-27 y of age-phenotypical of the US warfighter-will participate in a 12-wk, two-arm, single-blind, randomized, exercise dose-response trial comparing two intensities of combined training: Moderate-Intensity vs. High-Intensity. Biospecimens are collected before and after an acute exercise bout in the pre-training state, and again after 12 weeks of 3 d/wk combined exercise training. Numerous phenotyping assessments are collected before after the 12-week intervention period to associate exercise training outcomes with molecular changes in the skeletal muscle and blood biospecimens.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable healthy
Started Feb 2017
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 23, 2017
CompletedFirst Submitted
Initial submission to the registry
November 15, 2017
CompletedFirst Posted
Study publicly available on registry
December 21, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2021
CompletedOctober 7, 2021
October 1, 2021
4.4 years
November 15, 2017
October 5, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in muscle mass
Muscle mass is assessed using DXA (dual-energy X-ray absorptiometry)
16 weeks
Change in cardiorespiratory fitness (VO2max)
VO2max is assessed using via indirect calorimetry during a graded cycle ergometry protocol
16 weeks
Study Arms (2)
Moderate Intensity (MOD)
EXPERIMENTALEndurance Training (ET): 3 d/wk x 30 minutes (min) of steady-state, moderate-intensity exercise on a treadmill or stationary cycle ergometer at target heart rate (HR) = 65-75% of maximum oxygen consumption rate (VO2max). The two modes (treadmill, bicycle) are offered for variety, and each subject is required to use each mode at least 1 d/wk to prevent bias. Resistance training (RT): 2 d/wk consisting of a prescription engaging all major muscle groups in 10 movements. Excluding abdominal crunches, target intensity is 12 repetitions/set to volitional fatigue. Subjects complete 3 sets of each movement, with \~60 seconds (s) rest between sets. For each movement, resistance increases when 14 repetitions are achieved for 2 of 3 sets. HR is monitored throughout each session and stored for analysis.
High Intensity (HI)
EXPERIMENTALRT: The 2 d/wk RT prescription differs from the MOD arm only in intensity and rest intervals. The same approach to progression applies, but HI RT intensity targets 8-10 repetitions per set; thus, resistance loads increase when 10 repetitions are achieved for 2 of 3 sets. The HI arm performs "superset" training, pairing movements stressing different muscle groups, with only 30-45 s between. ET: In lieu of steady-state endurance exercise, the HI arm performs high-intensity interval training (HIIT) 3 d/wk using a mix of challenging, explosive movements at maximal intensity. 10 x 30 s maximal intensity intervals are separated by 30 s rest intervals. HR is monitored throughout each session and stored for analysis.
Interventions
Exercise prescription intensity is moderate
Eligibility Criteria
You may qualify if:
- Healthy 18-27 year olds who are not in the US armed forces
You may not qualify if:
- History of regular endurance or resistance training in past 12 months
- BMI\>30
- Inability to tolerate intense exercise
- Diabetes
- Uncontrolled hypertension
- Unstable or exercise induced angina pectoris or myocardial ischemia
- Vascular disease
- Neurologic disease
- Musculoskeletal disorder
- Mental health disorder
- Any chronic or infectious disease that would preclude full participation
- Lidocaine allergy
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Alabama at Birminghamlead
- Wright State Universitycollaborator
- Salk Institute for Biological Studiescollaborator
Study Sites (1)
University of Alabama at Birmingham, Center for Exercise Medicine
Birmingham, Alabama, 35205, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Marcas Bamman, PhD
University of Alabama at Birmingham
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Outcomes assessors analyzing biospecimen samples are blinded to the arm to which each participant has been randomly assigned when doing analysis. Investigators are blinded to each participant's randomized assignment.
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Site Principle Investigator
Study Record Dates
First Submitted
November 15, 2017
First Posted
December 21, 2017
Study Start
February 23, 2017
Primary Completion
July 30, 2021
Study Completion
July 31, 2021
Last Updated
October 7, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- De-identified data will be available 12 months after completion of the trial. Data will be publicly available indefinitely.
De-identified data will be available 12 months after completion of the trial. Data will be publicly available indefinitely. Data will include phenotyping test results and molecular mapping results.